Market Place
Sourcing Support
FDA approvals slump 19% in H1 2024; NASH, COPD, PAH get new treatment options
The first half of 2024 saw a significant slowdown in approvals of new drugs and biologics by the US
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
Top Pharma Companies & Drugs in 2023: Merck’s Keytruda emerges as top-selling drug; Novo, Lilly sales skyrocket
The pharma industry clearly recalibrated itself in 2023, turning its focus away from Covid and onto
Top Pharma Companies & Drugs in 2022: Pfizer breaks US$ 100 bn barrier, AbbVie’s Humira retains 2nd spot
In 2022, the pandemic continued to bring in a windfall for
pharmaceutical companies manufacturing C
Top Pharma Companies & Drugs in 2021: Covid vaccines, pills cause churn in list
Every year, the list of top pharmaceutical products and companies by sales sees some churn. But the
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Sales Forecast of FDA’s Novel Drugs Approvals in 2018
The year 2018 was a landmark year for the US Food and Drug Administration (FDA) as the agency approv
Top Pharma & Biotech Deals, Investments, M&As in August 2018
In August, the biotech boom of 2018 continued unabated and the Wall
Street Journal reported that in
Pharma & Biotech Deals, Investments and M&As in May 2018
As April 2018 breezed past with news of Novartis’ US$ 8.7 billion buyout of AveXis, May set th
